Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Pitini

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|January 10, 2006
Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinibVincenzo Pitini, Giuseppe Sturniolo, Vittorio Cavallari, et al.
Journal of Neuro-Oncology|March 5, 2008
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenomaVincenzo Pitini, Carmela Arrigo, Concetta Alafaci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Interleukin-2 and lymphokine-activated killer cell therapy in patients with relapsed B-cell lymphoma treated with rituximabVincenzo Pitini, Carmela Arrigo, Claudia Naro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Questionable validity of cardiac risk score on the basis of the NSABP B-31 modelVincenzo Pitini, Carmela Arrigo, Patrizia Mondello, et al.
Future Oncology (London, England)|April 3, 2015
Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitorsMariacarmela Santarpia, Giuseppe Altavilla, Vincenzo Pitini, et al.
Springerplus|July 22, 2014
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseasePatrizia Mondello, Michael Mian, Carmela Arrigo, et al.
British Journal of Haematology|November 30, 2004
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case reportVincenzo Pitini, Diana Teti, Carmela Arrigo, et al.
Haematologica|April 13, 2004
Fatal delayed diagnosis in a patient with Falciparum malariaVincenzo Pitini, Giuseppe Sturniolo, Antonio Cascio, et al.
European Journal of Haematology|August 23, 2006
An accessory spleen wrongly recognised as relapse by positron emission tomographyVincenzo Pitini, Giuseppe Navarra, Vittorio Cavallari, et al.
British Journal of Haematology|July 28, 2011
Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemiaVincenzo Pitini, Antonio Cascio, Carmela Arrigo, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|January 10, 2006
Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinibVincenzo Pitini, Giuseppe Sturniolo, Vittorio Cavallari, et al.
Journal of Neuro-Oncology|March 5, 2008
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenomaVincenzo Pitini, Carmela Arrigo, Concetta Alafaci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Interleukin-2 and lymphokine-activated killer cell therapy in patients with relapsed B-cell lymphoma treated with rituximabVincenzo Pitini, Carmela Arrigo, Claudia Naro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Questionable validity of cardiac risk score on the basis of the NSABP B-31 modelVincenzo Pitini, Carmela Arrigo, Patrizia Mondello, et al.
Future Oncology (London, England)|April 3, 2015
Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitorsMariacarmela Santarpia, Giuseppe Altavilla, Vincenzo Pitini, et al.
Springerplus|July 22, 2014
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseasePatrizia Mondello, Michael Mian, Carmela Arrigo, et al.
British Journal of Haematology|November 30, 2004
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case reportVincenzo Pitini, Diana Teti, Carmela Arrigo, et al.
Haematologica|April 13, 2004
Fatal delayed diagnosis in a patient with Falciparum malariaVincenzo Pitini, Giuseppe Sturniolo, Antonio Cascio, et al.
European Journal of Haematology|August 23, 2006
An accessory spleen wrongly recognised as relapse by positron emission tomographyVincenzo Pitini, Giuseppe Navarra, Vittorio Cavallari, et al.
British Journal of Haematology|July 28, 2011
Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemiaVincenzo Pitini, Antonio Cascio, Carmela Arrigo, et al.
Pageof 6